Skip to main content
SpineGuard logo

SpineGuard — Investor Relations & Filings

Ticker · ALSGD ISIN · FR0011464452 LEI · 969500Z4BRXQX6CSL565 PA Manufacturing
Open in API
Filings indexed 468 across all filing types
Latest filing 2018-12-12 Regulatory Filings
Country FR France
Listing PA ALSGD

About SpineGuard

https://www.spineguard.com/

SpineGuard is a medical technology company that develops and markets the proprietary Dynamic Surgical Guidance (DSG) technology. DSG is a radiation-free, real-time sensing platform designed to make spine surgery safer. The technology is embedded in the company's PediGuard family of smart drilling instruments, which assist surgeons in the accurate placement of skeletal implants, particularly pedicle screws. By differentiating tissue types at the instrument's tip, the devices provide audible and visual feedback to help anticipate potential breaches of the vertebral wall, thereby enhancing procedural safety and accuracy. SpineGuard's primary goal is to establish DSG as a standard of care for securing and streamlining skeletal implant placement.

Recent filings

Filing Released Lang Actions
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
Regulatory Filings Classification · 85% confidence The document is a press release dated December 12, 2018, announcing that SpineGuard has obtained CE marking for dental applications using its DSG® technology developed with Adin Group. It details a partnership, product commercialization plans, and includes quotes from management. This type of announcement, which is a specific corporate update regarding a product milestone (CE marking) and partnership development, does not fit neatly into the defined categories like 10-K (Annual Report), ER (Earnings Release), or CT (Call Transcript). It is a specific corporate action announcement. Since it is not a standard regulatory filing like a 10-K or a specific financial event like a dividend or capital change, and it is not a presentation (IP) or a management discussion (MDA), the most appropriate general category for a significant, non-standard corporate announcement that isn't covered elsewhere is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory/corporate news, although it is more specific than a typical RNS. However, given the options, this is a material corporate announcement about product/partnership development. It is not a Director's Dealing (DIRS), Capital Change (CAP), or M&A (TAR). It is closest to a general corporate news release. Given the strict definitions, RNS is the best fit as a general regulatory/corporate announcement fallback when a more specific code is unavailable for a press release detailing a business development milestone.
2018-12-12 French
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.)
Regulatory Filings Classification · 95% confidence The document is a press release announcing a significant business development: SpineGuard and Adin Group receiving a CE mark for a dental surgery instrument utilizing SpineGuard's DSG technology. This announcement details a partnership outcome, product commercialization plans, and includes standard 'About Us' sections for both companies. It is not a formal regulatory filing like a 10-K, an earnings release (ER), a dividend notice (DIV), or a management discussion (MDA). It is a specific business update regarding a product/technology application, which fits best under a general announcement category. Since it is not a specific filing type like M&A (TAR) or Capital Change (CAP), and it is a formal announcement, it falls under the general Regulatory Filings/Announcements category (RNS) as a fallback for significant, non-standard corporate news, or potentially a general Investor Relations communication, but RNS is the most appropriate catch-all for press releases of this nature.
2018-12-12 English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
Regulatory Filings Classification · 95% confidence The document is a press release announcing a multi-year partnership between SpineGuard and Carnot Interfaces to integrate SpineGuard's DSG technology with a surgical robot. It details the background, quotes executives, and provides company information. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a quarterly report (IR). It is a specific corporate announcement regarding strategic development and collaboration, which often falls under general regulatory news or investor relations updates. Since it is a specific announcement about a strategic business development (partnership), it is best classified as a general Regulatory Filing (RNS) as it doesn't fit the more specific categories like M&A (TAR), Capital Change (CAP), or Management Change (MANG). It is too detailed to be a simple Report Publication Announcement (RPA) as it contains substantive news, not just a notification of an attached report.
2018-12-05 French
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.)
Regulatory Filings Classification · 95% confidence The document is clearly formatted as a "*Press Release*" announcing a strategic partnership between SpineGuard and Carnot Interfaces regarding DSG technology and surgical robots. It contains forward-looking statements, quotes from management, and details about a future financial event ("Next financial press release: 2017 full year revenue, January 17, 2019"). This type of announcement, which is not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific financial report (IR, AR), is best classified as a general Regulatory Filing (RNS) or potentially an Investor Presentation (IP) if it were a slide deck. Given the format is a press release detailing business developments and partnerships, and it doesn't fit the specific definitions for ER, CT, CAP, or MANG, RNS serves as the most appropriate general regulatory announcement category for significant, non-standard corporate news.
2018-12-05 English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
Regulatory Filings Classification · 95% confidence The document is a press release dated June 14, 2018, announcing the publication of a preclinical study in a scientific journal regarding SpineGuard's DSG® technology in dental implantology, in partnership with Adin Dental Implant Systems. It includes quotes from management, details about the study's positive results, and mentions the next financial communication date (H1 2018 revenue on July 11, 2018). This type of announcement, detailing a specific scientific or business development (not a full financial report, earnings release, or management discussion), fits best under the general category of Regulatory Filings (RNS) or potentially Investor Presentation (IP) if it were a slide deck, but since it's a news announcement about a publication, RNS is the most appropriate general regulatory/news category, as it doesn't fit the specific financial report codes (10-K, IR, ER) or management/governance codes. Given the options, RNS serves as the best fit for a general corporate news announcement that isn't a core financial filing or a specific management/dividend notice.
2018-06-14 French
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.)
Regulatory Filings Classification · 93% confidence The document is a press release announcing the publication of a preclinical study in a peer-reviewed journal regarding SpineGuard's DSG technology used with Adin Dental Implant Systems. It contains quotes from CEOs, details about the study's findings, and information about the companies involved. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a formal report (AR, IR). It is an announcement about scientific/product development news. Since there is no specific category for 'Scientific Publication Announcement' and it is not a general regulatory filing (RNS) or an investor presentation (IP), the most appropriate category is Regulatory Filings (RNS) as a general announcement of material, non-financial news, or potentially a Legal Proceedings Report (LTR) if the study was regulatory in nature, but here it is clearly scientific/commercial news. Given the options, RNS serves as the best general announcement fallback for material news that isn't explicitly covered elsewhere. However, since it is a press release announcing a scientific milestone, and not a mandatory regulatory filing, RNS is the most suitable general category for non-standard announcements.
2018-06-14 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.